Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Kaye

Showing results (551-560 of 740) with videos related to

Pageof 74
Sort By:
Neurology International|November 21, 2020
Chronic Pain Treatment Strategies in Parkinson's DiseaseAmber Edinoff, Niro Sathivadivel, Timothy McBride, et al.
American Journal of Infection Control|May 20, 2014
Understanding health care personnel's attitudes toward mandatory influenza vaccinationReda A Awali, Preethy S Samuel, Bharat Marwaha, et al.
Eclinicalmedicine|December 4, 2025
Omadacycline versus moxifloxacin for community-acquired bacterial pneumonia (OPTIC-2): a phase 3b, randomised, double-blind, multicentre, controlled, noninferiority trialThomas M File, Keith S Kaye, Skliarov Ihor, et al.
Antimicrobial Agents and Chemotherapy|April 4, 2018
Relebactam Is a Potent Inhibitor of the KPC-2 β-Lactamase and Restores Imipenem Susceptibility in KPC-Producing EnterobacteriaceaeKrisztina M Papp-Wallace, Melissa D Barnes, Jim Alsop, et al.
Annals of Tropical Paediatrics|October 14, 2004
Dual HIV-1 and HIV-2 infection in a West African infantM A B van der Sande, T N Luong, M F Schim van der Loeff, et al.
Journal of Clinical Microbiology|May 30, 2008
Application of a novel, rapid, and sensitive oligonucleotide ligation assay for detection of cancer-predicting mutations in the precore and basal core promoter of hepatitis B virusM E Mendy, S Kaye, E Le Roux, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 14, 2019
Multidrug-resistant Organisms in Hospitals: What Is on Patient Hands and in Their Rooms?Lona Mody, Laraine L Washer, Keith S Kaye, et al.
Investigative Ophthalmology & Visual Science|March 19, 2010
Identification of novel mutations in the ortholog of Drosophila eyes shut gene (EYS) causing autosomal recessive retinitis pigmentosaMai M Abd El-Aziz, Ciara A O'Driscoll, Rebecca S Kaye, et al.
Pathogens & Immunity|April 22, 2017
A Comparison of Molecular Typing Methods Applied to <i>Enterobacter cloacae</i> complex: <i>hsp60</i> Sequencing, Rep-PCR, and MLSTRoberto A Viau, Lee M Kiedrowski, Barry N Kreiswirth, et al.
British Journal of Cancer|September 29, 2004
Phase I and pharmacokinetic study of XR11576, an oral topoisomerase I and II inhibitor, administered on days 1-5 of a 3-weekly cycle in patients with advanced solid tumoursM J A de Jonge, S Kaye, J Verweij, et al.
Pageof 74

Showing results (551-560 of 740) with videos related to

Sort By:
Pageof 74
Neurology International|November 21, 2020
Chronic Pain Treatment Strategies in Parkinson's DiseaseAmber Edinoff, Niro Sathivadivel, Timothy McBride, et al.
American Journal of Infection Control|May 20, 2014
Understanding health care personnel's attitudes toward mandatory influenza vaccinationReda A Awali, Preethy S Samuel, Bharat Marwaha, et al.
Eclinicalmedicine|December 4, 2025
Omadacycline versus moxifloxacin for community-acquired bacterial pneumonia (OPTIC-2): a phase 3b, randomised, double-blind, multicentre, controlled, noninferiority trialThomas M File, Keith S Kaye, Skliarov Ihor, et al.
Antimicrobial Agents and Chemotherapy|April 4, 2018
Relebactam Is a Potent Inhibitor of the KPC-2 β-Lactamase and Restores Imipenem Susceptibility in KPC-Producing EnterobacteriaceaeKrisztina M Papp-Wallace, Melissa D Barnes, Jim Alsop, et al.
Annals of Tropical Paediatrics|October 14, 2004
Dual HIV-1 and HIV-2 infection in a West African infantM A B van der Sande, T N Luong, M F Schim van der Loeff, et al.
Journal of Clinical Microbiology|May 30, 2008
Application of a novel, rapid, and sensitive oligonucleotide ligation assay for detection of cancer-predicting mutations in the precore and basal core promoter of hepatitis B virusM E Mendy, S Kaye, E Le Roux, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 14, 2019
Multidrug-resistant Organisms in Hospitals: What Is on Patient Hands and in Their Rooms?Lona Mody, Laraine L Washer, Keith S Kaye, et al.
Investigative Ophthalmology & Visual Science|March 19, 2010
Identification of novel mutations in the ortholog of Drosophila eyes shut gene (EYS) causing autosomal recessive retinitis pigmentosaMai M Abd El-Aziz, Ciara A O'Driscoll, Rebecca S Kaye, et al.
Pathogens & Immunity|April 22, 2017
A Comparison of Molecular Typing Methods Applied to <i>Enterobacter cloacae</i> complex: <i>hsp60</i> Sequencing, Rep-PCR, and MLSTRoberto A Viau, Lee M Kiedrowski, Barry N Kreiswirth, et al.
British Journal of Cancer|September 29, 2004
Phase I and pharmacokinetic study of XR11576, an oral topoisomerase I and II inhibitor, administered on days 1-5 of a 3-weekly cycle in patients with advanced solid tumoursM J A de Jonge, S Kaye, J Verweij, et al.
Pageof 74